Abstract
Interventions to improve muscle mass in COPD remain limited to exercise and nutrition. As novel drugs show promise, there should be focus on identifying target subgroups of patients, strategies to combine interventions and optimise outcome measures. https://bit.ly/3WI5Sjg.